Issues related to the impact of type 1 diabetes affect adults and can cause interpersonal challenges in partner relationships, according to a qualitative study published online March 8 in Diabetes Care.
What frequency of self monitoring of blood glucose is considered necessary for the most favorable glycemic control?
The TEDDY study, following nearly 9,000 at-risk children from birth to age 15, is enabling scientists to parse which genetic mutations correlate with progression or lack of progression to type 1 diabetes.
University of Missouri scientist Habib Zaghouani, PhD, is developing a potential cure for type 1 diabetes by combining adult stem cells with a promising new drug he developed at MU
Aggressive lowering of blood pressure may be associated with increased risk of coronary heart disease (CHD) in black or white patients with diabetes, according to research published online May 20 in Diabetes Care.
While media reports have been quick to label this a breakthrough in the study of treatments for type 2 diabetes, its value to T1D research has yet to be determined.
To ease the process for applicants, the school has developed the “Study Web Screener.” The screener is a short online questionnaire that helps speed up the screening process by quickly determining which clinical study you or a family member may be eligible for.
Understanding the ways in which the immune system normally controls and suppresses T cells is crucial to our understanding what goes wrong in autoimmune diseases, and also gives us new tools as we try to treat the incorrectly activated cells we see in type 1 diabetes.
A retrospective cohort study was recently published in the journal, Nephrology Dialysis Transplantation, focusing on the mortality rates of patients receiving a pancreas transplant compared to those who were on the waiting list with similar co-morbidities.
Wait, an algorithm? No, not the technology software kind. Rather, this “algorithm” is a set of complex guidelines for doctors that, according to the AACE, “considers the whole patient, the spectrum of risks and complications for the patient, and evidence-based approaches to treatment.”
An extended insulin-release system comprising an injectable gel of nanoparticles may one day help patients with type 1 diabetes manage their condition without having constantly to test their blood-sugar and inject themselves with insulin.
Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million Americans.
Diabetes UK have announced the biggest research program in the charity’s history to try and develop a new vaccine for Type 1 diabetes within the next two decades, an accomplishment which could transform and improve the lives of millions
Some of the earliest results from The Environmental Determinants of Diabetes in The Young (TEDDY) study – a major Europe-USA consortium exploring the causes of type 1 diabetes in children – has found no evidence for viral infection as a possible cause.
After more than three decades of research, a consortium of schools that includes the U has completed testing on the transplant technique.
An infectious disease carried by animals may trigger the development of type 1 diabetes, according to scientists in the UK.
People with type 1 diabetes who exercise may need to reduce their insulin to counteract the effects of their workouts, according to a new study.
The discovery may someday lead to a treatment for Type 2 diabetes, the most common form of the disease. People have their own version of this hormone, and the new work suggests that giving diabetics more of it might one remove the need to be treated with insulin injections
SOGA, a protein that lowers blood glucose, is missing in type 1 patients. SOGA is released when insulin is released and works by blocking the production of glycogen when food is being consumed.
The FDA recently approved the next-generation OmniPod from Insulet, giving people with insulin-dependent diabetes an even less invasive way to manage their diabetes.